Overview

A Single-dose Study of Intranasal Ketorolac in the Treatment of Pain Secondary to Dental Impaction Surgery

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the analgesic efficacy of a single intranasal (IN) administration of ketorolac after dental impaction surgery.
Phase:
Phase 2
Details
Lead Sponsor:
Egalet Ltd
Luitpold Pharmaceuticals
Treatments:
Ketorolac
Ketorolac Tromethamine